Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?

Endometrial cancer is the most common gynecologic malignancy in developed countries, with increasing incidence and mortality rates worldwide. While most cases are successfully treated with surgery, first-line treatment options for metastatic or recurrent endometrial cancer involve significant toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdi, Haider, Ray-Coquard, Isabelle, Lorusso, Domenica, Mirza, Mansoor Raza, Monk, Bradley J, Slomovitz, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646884/
https://www.ncbi.nlm.nih.gov/pubmed/37640446
http://dx.doi.org/10.1136/ijgc-2023-004454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646884/
https://www.ncbi.nlm.nih.gov/pubmed/37640446
http://dx.doi.org/10.1136/ijgc-2023-004454

Ejemplares similares